ABBOTINDIA stock news on Anadi Algo News

Sunday, March 29, 2026
DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|
AnadiAlgoNews
सट्टा नहीं, सिस्टम
Stock Landing|1 matching stories

ABBOTINDIA Share Price, Latest News & Sentiment

Latest AI-analyzed news for ABBOTINDIA, along with saved share-price context, sentiment, quarterly filing summary, and related names in one page.

Stock Coverage Hub

ABBOTINDIA News Today

Large-cap stock hub

The Indian pharmaceutical sector is experiencing significant growth, attracting global giants due to increased healthcare spending and a growing middle class. Companies focusing on consumer-driven segments are well-positioned.

Coverage
1
recent stories
Sources
1
distinct publishers
Bias Split
1 bullish / 0 bearish
0 neutral stories
Window
1d
recent coverage span
Saved Quote Snapshot

Abbott India Limited

Last Updated
28 Mar 2026
Price
Rs 26,480
+0.28%
52W Range
Rs 25,350 - Rs 37,000
exchange snapshot
PE / VWAP
PE NA
VWAP Rs 26,226.05
Trend Read
mixed
EMA stack mixed
Business Context
Industry: Pharmaceuticals
Sector Trail: NIFTY LARGEMIDCAP 250
Listing Date: 2010-01-08
Market Structure
F&O Eligible: No
Indices: NIFTY LARGEMIDCAP 250, NIFTY500 MULTICAP 50:25:25, NIFTY 500
Snapshot Source: mcp+nse
Quarterly Read

Quarterly results are being synced

saved filing pending
What We Can Read Right Now

The saved quarterly filing for ABBOTINDIA is not available on this page yet. The stock page is already showing saved price context and recent news flow, and the quarterly explanation block will appear once the filing sync completes for this symbol.

Current Read
  • The saved quote snapshot was up +0.28% on the day.
  • News flow is leaning constructive.
  • EMA stack mixed
What To Watch Next

Once the quarterly filing sync lands, check whether the saved results confirm the current news trend. If news is positive but the next saved filing is weak, that gap matters. If both align, the stock story becomes stronger.

Top Themes

Healthcare1 mentionsPharmaceuticals1 mentions

Related Stocks

Peer names will show up here once more related-stock mentions appear in coverage.

Key People

Management and deal-maker mentions will appear here when they show up in recent stories.

ABBOTINDIA FAQ

Why is ABBOTINDIA in the news right now?

ABBOTINDIA has appeared across 1 recent stories from 1 sources, which usually means there is a real flow of fresh headlines rather than a single isolated mention.

Is ABBOTINDIA coverage bullish or bearish right now?

ABBOTINDIA coverage is currently leaning bullish, with 1 bullish, 0 bearish, and 0 neutral analyzed stories in the recent window.

Which themes are moving with ABBOTINDIA?

Recent ABBOTINDIA coverage is clustering around Healthcare and Pharmaceuticals. Related names showing up alongside ABBOTINDIA include the wider peer basket.

How should I use this ABBOTINDIA news page?

Use this page as a coverage hub for ABBOTINDIA: start with the latest headlines, then check the dominant themes, related names, and saved market context before you form a trade or watchlist view.

Workflow View

Use ABBOTINDIA coverage to build a cleaner watchlist.

A stock page is most useful when it helps you slow down, compare headlines, and separate one-off noise from a repeatable setup.

Study Stock Execution

See a calmer workflow for converting ABBOTINDIA news into an actual plan.

Filter Related Names

Scanner-style filtering helps when one stock headline starts pulling attention across a cluster.

This is here if you want to go deeper, not as a push.Explore Anadi
Top Story|ValuePickrabout 4 hours ago

Abbott India: MNC pharma play on increased consumer spending

The Indian pharmaceutical sector is experiencing significant growth, attracting global giants due to increased healthcare spending and a growing middle class. Companies focusing on consumer-driven segments are well-positioned.

buy
Bullish+6060%
PharmaceuticalsHealthcare
+60

Impact Score

Affected Stocks

ABBOTINDIAAbbott India Ltd.
Positive
Maintain a bullish bias on Indian pharma stocks with strong brand presence and consumer-centric strategies, looking for entry points on minor pullbacks.